Latest News

Filters

Filter by tags: Radiopharmaceutical International Atomic Energy Agency Clear all tag filters

3 news articles found

Kyrgyzstan's Ministry of Health and Rosatom are working together on a new nuclear medicine diagnostic centre at the National Centre for Oncology and Haematology in Bishkek, with the latest stage being the delivery of a technetium-99m GT-4K generator.

Source: World Nuclear News
Date: Friday, 04 August 2023
Original article: world-nuclear-news.org/Articles/Nuclear-medicine-project-in-Kyrgyzstan-making-prog

Radioisotopes essential for diagnostics and treatment of severe diseases Brussels-based nuclear industry association Foratom has called on the European Union to better recognise and support the medical applications of nuclear technology, which play a significant role in the medical sector and help “save thousands of lives each day.”

Foratom said in a joint position paper with Nuclear Medicine Europe that EU policy makers should find ways of promoting new research reactor capacity along with innovation in the sector, and implement a number of recommendations to maintain the current level of medical radioisotopes supply.

According to the paper, in order to ensure that the supply of medical radioisotopes will be continued, the EU needs to develop a “robust” supply chain which goes beyond irradiation, adapt clinical research and development of new radiopharmaceutical compounds, and reconsider reimbursement systems for radiopharmaceutical products.

Source: Nucnet
Date: Wednesday, 16 June 2021
Original article: nucnet.org/news/foratom-urges-european-union-to-provide-more-support-for-nuclear-medicine-6-2-2021

Agency schedules webinar and warns of possible shortages at hospitals A researcher at Indonesia’s National Nuclear Agency using a hot cell to prepare a radiopharmaceutical. Courtesy M. Gaspar/IAEA. The production of radioisotopes used to produce radiopharmaceuticals for medical procedures has continued during the Covid-19 pandemic, but hospitals could face shortages due to bottlenecks in transport and distribution, the International Atomic Energy Agency has warned.

An agency survey conducted among operators of research reactors that produce radioisotopes for radiopharmaceuticals shows that most major actors continue to produce radioisotopes because the production facilities have been defined as essential by the relevant governments.

However, many airlines are no longer operating because of the pandemic and borders are closed, which affects the distribution of medical radioisotopes around the world.

Joao Osso Junior, head of the radioisotope products and radiation technology section at the IAEA, said the agency is working to assess the need for medical radioisotopes because most research and education activities using isotopes have been put on hold and many hospitals have delayed diagnosis applications.

Source: Nucnet
Date: Wednesday, 22 April 2020
Original article: nucnet.org/news/radioisotope-industry-facing-distribution-challenges-says-iaea-4-2-2020